Related Experiment Video
Updated: Jul 20, 2025

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
First Case of Cupravidus paculus Infection in a Lung Transplant Recipient: A Case Report
Aniruddh Shah1, Haytham Elgharably2, Atul Mehta3
1Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.
Abstract:
Cupravidus paculus is a rare Gram-negative bacterium that can cause a wide range of severe infections, largely in immunocompromised patients. It is a ubiquitous organism found in natural and man-made environments and in the hospital. Herein, we present the first case of C. paculus infection in a lung transplant recipient, which required prolonged antibiotic therapy to achieve complete clearance. Additionally, we review the existing literature on the clinical and microbiological profile of C. paculus, along with previously documented cases of clinical infections. Our case highlights the potential sources of C. paculus infections, the importance of appropriate disinfection protocols for medical devices, and the need for antibiotic sensitivities to guide treatment.
Insights
Cupravidus necator infections are rare but severe, especially in immunocompromised individuals. This study details the first lung transplant case, emphasizing prolonged treatment and disinfection protocols.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Transplantation Immunology
Background:
- Cupravidus necator is a rare Gram-negative bacterium causing severe infections, primarily in immunocompromised patients.
- This ubiquitous organism resides in diverse environments, including healthcare settings.
- Lung transplant recipients are a vulnerable population for opportunistic infections.
Observation:
- The first documented case of Cupravidus necator infection in a lung transplant recipient is presented.
- The infection necessitated extended antibiotic treatment for complete resolution.
- A comprehensive review of existing literature on C. necator clinical and microbiological profiles was conducted.
Findings:
- Cupravidus necator can cause severe infections in immunocompromised hosts, such as lung transplant recipients.
- Prolonged antibiotic therapy is crucial for eradicating C. necator infections.
- The study identified potential environmental and medical device sources of C. necator.
Implications:
- Highlights the importance of stringent disinfection protocols for medical devices to prevent C. necator transmission.
- Underscores the need for susceptibility testing to guide effective antibiotic treatment strategies.
- Emphasizes the potential for C. necator to cause severe infections in solid organ transplant recipients.
More Related Videos
10:01Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: